General Hospital of Eastern Theater Command
General Hospital of Eastern Theater Command
Nanjing, Jiangsu, China5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Lorlatinib Continuation Study | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 4 | 2026-09-23 | NCT05144997 | |
| A Clinical Study of FT1 in Patients With Short Bowel Syndrome | Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, digestive system disorder, intestinal disorder, macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, malabsorption syndrome, short bowel syndrome | Recruiting | Phase 2 | 2026-07-15 | NCT07704047 | |
| Phase IV Study of rhGH Injection in Adult Short Bowel Syndrome | Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, digestive system disorder, intestinal disorder, malabsorption syndrome, short bowel syndrome | Recruiting | Phase 4 | 2026-07-08 | NCT07691125 | |
| Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy | Primary Membranous Nephropathy | Recruiting | Phase 2 | 2026-01-26 | NCT07289763 | |
| Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer | Advanced Lung Cancer | Recruiting | Phase 1 | 2025-05-28 | NCT06992583 |